Criteo S.A. (NASDAQ: CRTO) filing shows insider sales and 45,677 shares listed

Rhea-AI Filing Summary

Criteo S.A. reported insider sales and a planned disposition of ordinary shares. The filing lists 45,677 ordinary shares tied to performance stock units and restricted stock units (vesting referenced with 03/02/2026), and shows two recent sales by Sarah Glickman: 1,541 shares on 02/24/2026 for $25,753.35 and 2,796 shares on 02/23/2026 for $47,014.46.

Insights

Compliance Counsel

Filed Form 144 documents reported sale transactions and a scheduled resale of vested equity.

Form indicates a planned resale of 45,677 ordinary shares tied to performance stock units and RSUs with a vesting reference of 03/02/2026. Two executed transactions by Sarah Glickman are dated 02/23/2026 and 02/24/2026, with aggregate proceeds shown.

These entries are disclosure-driven; cash‑flow treatment and any broker/dealer distribution methods are not detailed in the excerpt. Subsequent filings or broker confirmations would show settlement and exact distribution mechanics.

Equity Compensation Analyst

The filing lists vested equity and small open‑market dispositions by an insider.

The record ties 45,677 shares to compensation awards (performance stock units and RSUs) with a vesting reference of 03/02/2026. Separately, the excerpt reports two small sales by Sarah Glickman totaling $72,767.81.

These amounts are routine for vested awards and do not by themselves quantify dilution; plan reserve or outstanding share context is not provided in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS INC 390 GREENWICH STREET NEW YORK NY 10013	18304	329372.53	49859086	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	03/02/2024	PERFORMANCE STOCK UNITS VESTING AND RESTRICTED STOCK UNITS VESTING	CRITEO S.A.			45677	03/02/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SARAH GLICKMAN 32 RUE BLANCHE PARIS I0 75009	ORDINARY SHARES	02/24/2026	1541	25753.35
SARAH GLICKMAN 32 RUE BLANCHE PARIS I0 75009	ORDINARY SHARES	02/23/2026	2796	47014.46

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the CRTO Form 144 filing disclose about shares to be sold?

The filing lists 45,677 ordinary shares tied to performance stock units and RSUs with a vesting reference of 03/02/2026. This line appears under the "Securities To Be Sold" section and is labeled as compensation.

How many shares did Sarah Glickman sell according to the filing?

The filing records two sales by Sarah Glickman: 2,796 shares on 02/23/2026 for $47,014.46 and 1,541 shares on 02/24/2026 for $25,753.35, as shown in the "Securities Sold During The Past 3 Months" section.

Are the proceeds from the reported sales paid to Criteo (CRTO)?

The excerpt shows aggregate dollar amounts for the two sales ($47,014.46 and $25,753.35), but it does not state who received proceeds. The filing does not specify issuer proceeds or selling‑holder treatment in the provided lines.

Do the reported items indicate dilution or new shares issued by CRTO?

The filing ties 45,677 shares to compensation awards, but the excerpt does not state total outstanding shares or whether these shares are newly issued. The excerpt does not provide a clear dilution calculation or plan reserve numbers.